Tech Company Financing Transactions
CinRx Pharma Funding Round
CinRx Pharma closed a $73 million funding round on 6/2/2024. Investors included private investors.
Transaction Overview
Company Name
Announced On
6/2/2024
Transaction Type
Venture Equity
Amount
$73,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to advance development of its existing portfolio programs and assets to expand in key areas of high unmet medical need.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
5375 Medpace Way
Cincinnati, OH 45227
USA
Cincinnati, OH 45227
USA
Phone
Website
Email Address
Overview
CinRx Pharma is a biotech company accelerating promising, high-impact medicines through clinical development with a unique hub and spoke model. This approach enables us to efficiently progress our portfolio of CinCos with the pre-clinical, clinical, and operational expertise required along with finaning optionality.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jon Isaacsohn
Chief Medical Officer
Brian Murphy
Chief Scientific Officer
Mary Bond
VP - Administration
Sally Dressman
VP - Bus. Development
Gavin Samuels
Browse more venture capital transactions:
Prev: 6/2/2024: Flam venture capital transaction
Next: 6/3/2024: Summit Therapeutics venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs